Europe begins using AstraZeneca's COVID-19 vaccine again after EU drug regulator confirms its safety
Germany, France, Italy, and Spain resumed use of the Oxford-AstraZeneca COVID-19 vaccine on Thursday, hours after the European Union's drug regulator, the European Medicines Agency, said a review of the data confirmed that the vaccine is safe and effective. Norway is awaiting further research. The EMA said it found no increased risk of blood clots from AstraZeneca's vaccine, though a warning label will be affixed advising doctors and other medical experts to watch out for a rare form of clotting and bleeding in the brain.
Even if a link emerged between cerebral venous thrombosis and the vaccine, the EMA said, AstraZeneca's shots will prevent much more illness and death than they could cause. Europe is buckling under another wave of COVID-19 infections and deaths, and the World Health Organization says it isn't vaccinating its population quickly enough to slow transmission.
The decision by several European countries to pause use of the AstraZeneca vaccine not only hindered the EU's vaccination effort, it might also have irrevocably damaged trust in that vaccine — which, like all the others approved for use, has proved incredibly effective at preventing serious illness and death from COVID-19. AstraZeneca's vaccine is also central to the effort to inoculate the developing world, because it is easier to store and not currently being sold at profit. Europe's pause appears to have dented confidence in the vaccine in those countries, too.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published